Role of DNA repair defects in predicting immunotherapy response
Abstract Defect in DNA damage response (DDR) is a common feature of cancer cells, which regulates tumor growth and therapeutic response. Recently, the approval of immune checkpoint blockade (ICB) for tumors with defective mismatch repair has paved the way for investigating the role of other DDR defe...
Main Authors: | Jing Zhang, David J. H. Shih, Shiaw-Yih Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-020-00202-7 |
Similar Items
-
DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
by: Mu Chen, et al.
Published: (2022-05-01) -
Editorial: The impact of the DNA damage response on anti-tumor immunity
by: Gang Chen, et al.
Published: (2022-09-01) -
A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer
by: Binbin Yuan, et al.
Published: (2022-05-01) -
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
by: Niklas Klümper, et al.
Published: (2023-12-01) -
Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
by: Zhihao Lu, et al.
Published: (2020-08-01)